Breaking News, Financial News

Financial Report: Covance 2Q

Late-Stage Development revenues in the quarter were flat at $267.0 million.

Covance 2Q

2Q Revenues:
$500.7 million (+2%)

2Q Earnings: $31.7 million (-26%)

YTD Revenues:
$1.0 billion (+5%)

YTD Earnings: $70.8 million (-15%)

Comments:
Late-Stage Development revenues in the quarter were flat at $267.0 million. Early Development revenues were $208.2 million (+4%). Backlog at June 30, 2010 grew 4% to $4.8 billion but was negatively impacted by Foreign exchange by $31 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters